Palvella Therapeutics (PVLA) PT Raised to $240 at Chardan

March 31, 2026 4:41 PM

Chardan analyst Geulah Livshits raised the price target on Palvella Therapeutics (NASDAQ: PVLA) to $240.00 (from $210.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found